Abcam vs En Carta Diagnostics
Abcam vs En Carta Diagnostics, compared side by side on 15 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Abcam is on 61/100 and En Carta Diagnostics on 52/100.
Where each one leads
Abcam
- our overall score: 61/100 against 52/100
- domain rating: 72/100 against 0/100
- funding raised: $257M against $5.0M
En Carta Diagnostics
Leads on none of the measures we hold for both companies.
At a glance
| Measure | Abcam | En Carta Diagnostics |
|---|---|---|
| What it is | Global supplier of life science research tools, including antibodies, reagents, and assays. | Developing a new generation of molecular diagnostics for at-home use, combining laboratory accuracy with rapid test simplicity. |
| Category | Biotechnology, Life Sciences, Discovery Tools, Antibodies | Biotechnology, HealthTech, Diagnostics, Medical Devices |
| Sells toBusiness model | B2B | B2B2C |
| Offering | Software | hardware | services | marketplace | platform | Hardware |
| Founded | 1998 | 2022 |
| Headquarters | Cambridge, United Kingdom | Paris, France |
| Status | Active | Inactive |
Size, funding and growth
| Measure | Abcam | En Carta Diagnostics |
|---|---|---|
| Employees | Not published | 12 |
| Total funding | $257M | $5.0M |
| Latest round | Series D | Seed |
| LinkedIn followers | Not published | 2,091 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Abcam | En Carta Diagnostics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 61/100 | 52/100 |
| Traction | 40/100 | 45/100 |
| Team | 70/100 | 70/100 |
| Community | 15/100 | Not published |
| Search visibility | 16/100 | 20/100 |
| Quality | 78/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (22/100) | Not published |
| Domain ratingLink authority, 0-100 | 72/100 | 0/100 |
Abcam vs En Carta Diagnostics: common questions
Which is better, Abcam or En Carta Diagnostics?
On our 0-100 score Abcam rates higher (61/100 against 52/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 15 data points above: read the rows that match what you are buying for.
How do Abcam and En Carta Diagnostics compare on the numbers?
Abcam leads on our overall score (61/100 against 52/100), domain rating (72/100 against 0/100), funding raised ($257M against $5.0M).
Read the full Abcam review and pricing or the En Carta Diagnostics review and pricing. You can also browse other Abcam alternatives we track.